Global Medical Robotics Market is projected to exhibit a significant growth, at a CAGR of around 18.2%, during the forecast period. The trend towards robotics and high-precision instrumentation and the constant development of minimally invasive surgeries facilitates the surgeons to offer improved patient’s outcomes. Minimally invasive surgery has been gaining significant popularity for the treatment of cancer. Laparoscopic surgery and robotic-assisted surgery are used for the treatment of pancreatic cancer, lung cancer and others. For lung cancer, robotic-assisted surgical instrument, da Vinci surgery is carried out with a few small incisions between the ribs. As a result, it avoids possibility of spreading ribs and a large incision.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/medical-robotics-market
Due to small incisions and a less, invasive technique enables patients of lung cancer to return to normal everyday activities faster, without any long recovery duration that is needed after a major lung procedure. Intuitive Surgical, Inc. shipped 220 da Vinci surgical systems in the second quarter of 2018 compared to 166 in the second quarter of 2017. It represents the growing demand for advanced robotic technologies for surgery across the globe. Moreover, for cardiac surgery, the demand for aortic valve replacement devices are rising due to heart failures, coronary artery disease and so on. It can be treated using artificial heart valves that enables patients to live normal life. Today, the use of artificial heart valves has significantly increased due to improved patients’ outcomes and technological innovations, which is offering growth to the global medical robotics market.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/medical-robotics-market
Robotic-assisted surgery, laparoscopy and other minimally invasive procedures enables patients to recover quickly with less trauma. However, in case of robotic-assisted surgery, the return to normal daily activities (except strenuous exercise and lifting heavy objects) occur in as little as two to three weeks. Additionally, some procedures can be carried out as an outpatient procedure, such as spinal stenosis or disc herniations and patients are usually discharged home under two to three hours after the procedure. The average hospital stay is not more than two days. Most patients can return to activities of everyday living and work under one to four weeks. As shorter incisions are involved that leads to faster healing and recovery from the condition and ultimately reduced hospital stay. These features enhance the growth of the global medical robotics market.
Recently, the developments in robotic-assisted surgeries, image-guided devices and other MIS tools has reported during the last decade. For instance: in March 2017, Stryker Corporation declared the commercial launch of robotic arm assisted total knee arthroplasty application for utilization with its Mako System. This advancement differentiates the Mako system as the first and only robotic technology that can be utilized across the joint replacement procedures to perform total hip, total knee, and partial knee replacements. Such advancements in the surgical procedures have been offering growth to the global medical robotics market.
Global Medical robotics Market-Segmentation
By Product
- Surgical Robotic Systems
- Rehabilitative Robotic Systems
- Noninvasive Radiosurgery Robots
- Hospital & Pharmacy Robotic Systems
- Others (Neuromate surgical system)
Global Medical robotics Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
Company Profiles
- Accuray Inc.
- Auris Health, Inc.
- AVRA Medical Robotics, Inc.
- CMR Surgical Ltd.
- Global Medical, Inc.
- Hocoma AG
- InTouch Technologies, Inc.
- Intuitive Surgical, Inc.
- Kirby Lester
- Medrobotics Corp.
- Medtronic PLC
- Microbot Medical Inc.
- Omnicell, Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
